EP Patent

EP0704209A1 — Transdermally active pharmaceutical composition containing 5-aminolaevulinic acid

Assigned to Ethicon Inc · Expires 1996-04-03 · 30y expired

What this patent protects

This invention relates to a ready-to-use, storage stable composition for use in the treatment of cancer which contains 5-aminolaevulinic acid or its derivatives and has a pH from about 1.8 to about 4.5.

USPTO Abstract

This invention relates to a ready-to-use, storage stable composition for use in the treatment of cancer which contains 5-aminolaevulinic acid or its derivatives and has a pH from about 1.8 to about 4.5.

Drugs covered by this patent

aminolevulinic-acid-hydrochloride (AMINOLEVULINIC ACID HYDROCHLORIDE)

Patent Metadata

Patent number: EP0704209A1
Jurisdiction: EP
Classification: —
Expires: 1996-04-03
Drug substance claim: No
Drug product claim: No
Assignee: Ethicon Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.